Byron Kwock Lee, MD
Cardiac Electrophysiology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Lee’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A54582 · Current
Licensed to practise in California · since 1995 · expires 2027-01-31 · Harvard Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$75,289
Medicare paid this office $75,289 for 804 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 98 | $11,901 | $109 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 138 | $7,538 | $23 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 72 | $4,477 | $28 |
| Return visit (30+ min) | 61 | $4,066 | $66 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 346 | $2,835 | $7 |
See all 15 services
| Long return visit (40+ min) | 98 | $11,901 | $109 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 138 | $7,538 | $23 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 72 | $4,477 | $28 |
| Return visit (30+ min) | 61 | $4,066 | $66 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 346 | $2,835 | $7 |
| External shock to heart to regulate heart beat | 22 | $2,238 | $93 |
| Programming of dual lead pacemaker system | 62 | $1,801 | $27 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 17 | $1,696 | $68 |
| New patient visit (60+ min) | 13 | $1,672 | $129 |
| Programming of dual lead implantable defibrillator system | 16 | $838 | $47 |
| Programming of multiple lead implantable defibrillator system | 14 | $751 | $47 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 51 | $696 | $14 |
| Programming of multiple lead pacemaker system | 14 | $575 | $34 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 69 | $457 | $6 |
| Programming of single lead pacemaker system | 14 | $275 | $18 |
Procedures Medicare counted
| Pacemaker insertion or repair | 1-10 | None |
Who their Medicare patients are
804 Original Medicare patients in 2024. Average age 76 · Under 65 10% · 85 and older 22% · Women 43% · Also on Medicaid 40% · Health risk score 2.44. Sicker patients than 9 in 10 peers; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Atrial fibrillation 56% · Heart failure 48% · Coronary heart disease 47% · Chronic kidney disease 45% · Diabetes 40% · Depression 25% · Cancer 22% · COPD 20% · Dementia 17% · Stroke 17%.
The office billed $610,159, Medicare allowed $102,843 and paid $75,289; for 1,532 services of 57 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 804 | 1,532 | 76 | 2.44 | $610,159 | $75,289 |
| 2023 | 1,692 | 3,203 | 74 | 2.33 | $1,248,776 | $135,725 |
| 2022 | 2,054 | 3,719 | 74 | 2.26 | $1,057,647 | $126,682 |
| 2021 | 1,922 | 3,674 | 74 | 2.44 | $845,174 | $112,576 |
| 2020 | 1,673 | 3,004 | 73 | 2.51 | $872,557 | $112,927 |
| 2019 | 1,779 | 2,832 | 73 | 2.53 | $972,185 | $109,636 |
| 2018 | 1,410 | 2,230 | 72 | 2.53 | $769,163 | $109,831 |
| 2017 | 1,063 | 1,733 | 73 | 2.41 | $759,566 | $103,695 |
| 2016 | 1,329 | 2,141 | 73 | 2.38 | $869,548 | $118,514 |
| 2015 | 1,337 | 2,176 | 72 | 2.41 | $730,276 | $108,682 |
| 2014 | 1,439 | 2,531 | 72 | 2.24 | $654,362 | $97,138 |
| 2013 | 1,096 | 1,911 | 72 | 2.28 | $528,892 | $78,316 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 19 services
| Long return visit (40+ min) | 135 | $19,908 | $117 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 152 | $12,136 | $24 |
| Insertion of implantable defibrillator system | 13 | $10,435 | $803 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 1,126 | $10,082 | $7 |
| Return visit (30+ min) | 108 | $8,999 | $78 |
| New patient visit (60+ min) | 59 | $8,987 | $152 |
| Removal of dual electrodes from right heart | 14 | $7,278 | $520 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 75 | $6,917 | $29 |
| Programming of dual lead pacemaker system | 88 | $3,471 | $29 |
| External shock to heart to regulate heart beat | 26 | $2,560 | $95 |
| Programming of multiple lead implantable defibrillator system | 30 | $2,162 | $51 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 15 | $1,743 | $21 |
| Removal of permanent pacemaker pulse generator | 12 | $1,365 | $114 |
| Programming of dual lead implantable defibrillator system | 19 | $1,171 | $49 |
| Programming of multiple lead pacemaker system | 15 | $817 | $34 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 103 | $684 | $7 |
| Programming of single lead pacemaker system | 21 | $652 | $25 |
| Programming of single lead implantable defibrillator system | 12 | $491 | $35 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 13 | $205 | $16 |
2022: 18 services
| Long return visit (40+ min) | 134 | $17,463 | $113 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 1,486 | $13,782 | $7 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 151 | $11,501 | $24 |
| New patient visit (60+ min) | 57 | $8,779 | $154 |
| Return visit (30+ min) | 101 | $8,259 | $75 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 75 | $6,840 | $28 |
| Removal and replacement of dual lead permanent pacemaker | 11 | $3,477 | $316 |
| Programming of dual lead pacemaker system | 75 | $3,271 | $32 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 21 | $3,002 | $91 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $1,932 | $176 |
| Programming of multiple lead implantable defibrillator system | 26 | $1,886 | $52 |
| External shock to heart to regulate heart beat | 18 | $1,774 | $99 |
| Extended patient service without direct patient contact, first hour | 16 | $1,635 | $96 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 15 | $1,407 | $88 |
| Programming of dual lead implantable defibrillator system | 18 | $1,228 | $49 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 157 | $1,109 | $7 |
| Programming of multiple lead pacemaker system | 19 | $934 | $37 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 14 | $260 | $17 |
2021: 16 services
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 1,489 | $15,429 | $7 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 141 | $10,961 | $24 |
| Long return visit (40+ min) | 78 | $9,598 | $114 |
| Return visit (30+ min) | 105 | $8,733 | $79 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 77 | $6,639 | $29 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 11 | $4,616 | $420 |
| New patient visit (60+ min) | 21 | $3,182 | $152 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 12 | $3,077 | $256 |
| Programming of dual lead pacemaker system | 60 | $2,535 | $30 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 11 | $2,107 | $22 |
| Programming of multiple lead implantable defibrillator system | 21 | $1,824 | $57 |
| Programming of dual lead implantable defibrillator system | 18 | $1,147 | $50 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 112 | $772 | $7 |
| Programming of multiple lead pacemaker system | 12 | $664 | $39 |
| Telephone medical discussion with physician, 11-20 minutes | 11 | $609 | $55 |
| Programming of single lead implantable defibrillator system | 11 | $542 | $34 |
2020: 14 services
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 1,252 | $13,686 | $8 |
| Long return visit (40+ min) | 105 | $10,561 | $84 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 126 | $7,578 | $27 |
| Return visit (30+ min) | 95 | $6,520 | $61 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 58 | $4,362 | $32 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 15 | $3,924 | $262 |
| Programming of dual lead pacemaker system | 66 | $2,768 | $32 |
| New patient visit (60+ min) | 21 | $2,753 | $131 |
| Telephone medical discussion with physician, 21-30 minutes | 33 | $2,574 | $68 |
| External shock to heart to regulate heart beat | 12 | $1,212 | $101 |
| Programming of dual lead implantable defibrillator system | 14 | $801 | $47 |
| Programming of multiple lead implantable defibrillator system | 11 | $784 | $52 |
| Telephone medical discussion with physician, 11-20 minutes | 13 | $558 | $43 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 70 | $401 | $6 |
2019: 17 services
| Long return visit (40+ min) | 149 | $16,072 | $88 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 1,289 | $13,236 | $7 |
| Insertion of implantable defibrillator system | 11 | $8,801 | $800 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 14 | $5,786 | $413 |
| Return visit (30+ min) | 81 | $5,668 | $64 |
| Programming of dual lead pacemaker system | 126 | $5,056 | $33 |
| New patient visit (60+ min) | 20 | $2,737 | $137 |
| External shock to heart to regulate heart beat | 24 | $2,528 | $97 |
| New patient visit (45+ min) | 17 | $1,963 | $115 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 37 | $1,470 | $28 |
| Programming of multiple lead implantable defibrillator system | 24 | $1,329 | $51 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 25 | $1,322 | $39 |
| Programming of dual lead implantable defibrillator system | 17 | $1,008 | $50 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 140 | $932 | $7 |
| Programming of multiple lead pacemaker system | 13 | $672 | $37 |
| Programming of single lead pacemaker system | 12 | $477 | $30 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 12 | $444 | $34 |
2018: 16 services
| Insertion of implantable defibrillator system | 14 | $11,247 | $803 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 1,003 | $10,089 | $7 |
| Long return visit (40+ min) | 98 | $9,755 | $86 |
| Return visit (30+ min) | 104 | $7,129 | $60 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 11 | $4,945 | $450 |
| Insertion of left lower heart electrode for pacemaker or defibrillator | 12 | $4,848 | $404 |
| Removal and replacement of dual lead permanent pacemaker | 12 | $3,593 | $299 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 12 | $3,396 | $283 |
| Programming of dual lead pacemaker system | 80 | $3,090 | $28 |
| New patient visit (45+ min) | 13 | $1,483 | $114 |
| Programming of multiple lead implantable defibrillator system | 22 | $1,478 | $49 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 22 | $1,348 | $45 |
| Removal of defibrillator | 12 | $1,262 | $105 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 40 | $1,228 | $23 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 97 | $729 | $7 |
| Programming of single lead pacemaker system | 15 | $440 | $26 |
2017: 16 services
| Long return visit (40+ min) | 90 | $10,169 | $92 |
| Return visit (30+ min) | 127 | $9,517 | $61 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 17 | $7,265 | $427 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 658 | $6,063 | $8 |
| Programming of dual lead pacemaker system | 99 | $5,033 | $29 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 15 | $2,713 | $181 |
| Programming of multiple lead implantable defibrillator system | 29 | $2,460 | $52 |
| New patient visit (60+ min) | 15 | $2,115 | $141 |
| External shock to heart to regulate heart beat | 19 | $1,872 | $99 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 12 | $983 | $82 |
| Programming of dual lead implantable defibrillator system | 13 | $983 | $45 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 13 | $865 | $58 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 23 | $824 | $27 |
| Programming of single lead pacemaker system | 15 | $560 | $28 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 57 | $438 | $8 |
| Short return visit (20+ min) | 12 | $319 | $27 |
2016: 19 services
| Return visit (30+ min) | 128 | $11,788 | $64 |
| Long return visit (40+ min) | 71 | $8,477 | $94 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 879 | $8,113 | $8 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 14 | $5,867 | $419 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 16 | $5,485 | $343 |
| Programming of dual lead pacemaker system | 99 | $5,451 | $32 |
| Programming of multiple lead implantable defibrillator system | 37 | $4,157 | $56 |
| New patient visit (60+ min) | 25 | $3,758 | $150 |
| External shock to heart to regulate heart beat | 24 | $2,665 | $111 |
| Programming of dual lead implantable defibrillator system | 29 | $2,321 | $48 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 12 | $2,155 | $180 |
| New patient visit (45+ min) | 21 | $2,111 | $101 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 11 | $1,425 | $130 |
| Hospital discharge day management, 30 minutes or less | 13 | $853 | $66 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 101 | $784 | $7 |
| Programming of single lead implantable defibrillator system | 11 | $772 | $37 |
| Programming of single lead pacemaker system | 19 | $674 | $27 |
| Short return visit (20+ min) | 12 | $413 | $34 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 11 | $369 | $31 |
2015: 15 services
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 1,071 | $10,802 | $7 |
| Return visit (30+ min) | 111 | $10,319 | $61 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 11 | $8,122 | $738 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 18 | $7,787 | $433 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 17 | $6,563 | $345 |
| Long return visit (40+ min) | 38 | $4,340 | $92 |
| Programming of dual lead pacemaker system | 71 | $3,541 | $32 |
| Programming of multiple lead implantable defibrillator system | 30 | $3,025 | $54 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 14 | $2,493 | $178 |
| New patient visit (60+ min) | 16 | $2,298 | $144 |
| External shock to heart to regulate heart beat | 16 | $2,025 | $112 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 14 | $1,261 | $90 |
| New patient visit (45+ min) | 11 | $1,259 | $114 |
| Programming of dual lead implantable defibrillator system | 14 | $1,051 | $48 |
| Programming of single lead pacemaker system | 13 | $507 | $27 |
2014: 15 services
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 1,209 | $13,725 | $7 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 18 | $8,173 | $454 |
| Return visit (30+ min) | 92 | $7,871 | $63 |
| Long return visit (40+ min) | 40 | $4,161 | $85 |
| Programming of multiple lead implantable defibrillator system | 27 | $3,688 | $55 |
| Programming of dual lead pacemaker system | 67 | $3,453 | $31 |
| New patient visit (60+ min) | 22 | $3,113 | $142 |
| New patient visit (45+ min) | 25 | $2,905 | $116 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 13 | $2,529 | $181 |
| Programming of dual lead implantable defibrillator system | 18 | $1,829 | $51 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $1,299 | $93 |
| External shock to heart to regulate heart beat | 11 | $1,222 | $111 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 12 | $1,076 | $90 |
| Short return visit (20+ min) | 19 | $823 | $43 |
| Programming of single lead pacemaker system | 15 | $469 | $22 |
2013: 10 services
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 897 | $8,852 | $7 |
| Long return visit (40+ min) | 45 | $5,868 | $92 |
| Return visit (30+ min) | 68 | $5,679 | $59 |
| Programming of multiple lead implantable defibrillator system | 21 | $2,993 | $50 |
| Programming of dual lead pacemaker system | 59 | $2,974 | $28 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 14 | $2,453 | $175 |
| New patient visit (45+ min) | 23 | $2,258 | $98 |
| New patient visit (60+ min) | 15 | $2,077 | $138 |
| External shock to heart to regulate heart beat | 17 | $1,839 | $108 |
| Programming of dual lead implantable defibrillator system | 16 | $1,765 | $44 |
Medicaid work
$11,054 in 2024
Medicaid paid $11,054 for 381 billed services this clinician did in 2024, up to 68 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 316 | $5,658 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, leadless pacemaker system, or implantable defibrillator system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | 39 | $3,838 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead implantable defibrillator system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional | 13 | $1,073 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, or leadless pacemaker system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional | 13 | $485 |
| 2024 | 381 | 4 | 68 | $11,054 |
| 2023 | 1,574 | 4 | 154 | $28,979 |
| 2022 | 2,090 | 4 | 198 | $32,696 |
| 2021 | 2,406 | 4 | 261 | $31,428 |
| 2020 | 1,888 | 2 | 269 | $24,528 |
| 2019 | 1,635 | 2 | 171 | $17,078 |
| 2018 | 1,406 | 1 | 145 | $14,146 |
See the largest Medicaid services in earlier years
2023
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1,421 | $23,316 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, or leadless pacemaker system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional | 98 | $3,534 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead implantable defibrillator system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional | 43 | $2,129 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, leadless pacemaker system, or implantable defibrillator system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | 12 | $0 |
2022
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1,899 | $28,463 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead implantable defibrillator system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional | 58 | $2,698 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, or leadless pacemaker system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional | 87 | $1,536 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, leadless pacemaker system, or implantable defibrillator system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | 46 | $0 |
2021
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 2,138 | $27,607 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, or leadless pacemaker system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional | 145 | $2,459 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead implantable defibrillator system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional | 41 | $1,362 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, leadless pacemaker system, or implantable defibrillator system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | 82 | $0 |
2020
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1,848 | $23,986 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, or leadless pacemaker system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional | 40 | $541 |
2019
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1,623 | $17,078 |
| Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 12 | $0 |
2018
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1,406 | $14,146 |
Drugs they prescribed that Part D paid
$71,503
Pharmacies billed $71,503 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 211) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
162 generic and fewer than 11 brand-name prescriptions · $71,503 in drug cost · 17 antibiotic prescriptions to 17 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 41 | $48,841 | $1,191 |
| Propafenone Hcl Er | 16 | $4,610 | $288 |
| Flecainide Acetate | 31 | $1,695 | $55 |
| Amiodarone | 18 | $1,198 | $67 |
| Metoprolol | 60 | $806 | $13 |
See all 6 drugs
| Eliquis | 41 | $48,841 | $1,191 |
| Propafenone Hcl Er | 16 | $4,610 | $288 |
| Flecainide Acetate | 31 | $1,695 | $55 |
| Amiodarone | 18 | $1,198 | $67 |
| Metoprolol | 60 | $806 | $13 |
| Cephalexin | 14 | $57 | $4 |
Year by year
| 2024 | 211 | 73 | 0% (0) | None | $71,503 |
| 2023 | 372 | 106 | 0% (0) | None | $177,265 |
| 2022 | 536 | 131 | 0% (0) | None | $262,747 |
| 2021 | 621 | 136 | 0% (0) | 37% | $277,473 |
| 2020 | 618 | 155 | 0% (0) | 34% | $245,097 |
| 2019 | 607 | 151 | 0% (0) | 37% | $234,396 |
| 2018 | 362 | 129 | None | 27% | $87,742 |
| 2017 | 346 | 114 | None | 29% | $75,232 |
| 2016 | 351 | 103 | 0% (0) | 34% | $73,400 |
| 2015 | 351 | 107 | None | 25% | $65,622 |
| 2014 | 305 | 78 | None | 19% | $53,460 |
| 2013 | 366 | 83 | None | 21% | $59,686 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 8 drugs
| Eliquis | 88 | $119,445 | $1,357 |
| Xarelto | 28 | $27,965 | $999 |
| Propafenone Hcl Er | 26 | $8,020 | $308 |
| Flecainide Acetate | 38 | $3,436 | $90 |
| Amiodarone | 15 | $1,720 | $115 |
| Metoprolol | 79 | $1,584 | $20 |
| Metoprolol | 13 | $172 | $13 |
| Cephalexin | 15 | $109 | $7 |
2022: 11 drugs
| Eliquis | 136 | $167,147 | $1,229 |
| Xarelto | 40 | $46,854 | $1,171 |
| Propafenone Hcl Er | 47 | $18,809 | $400 |
| Flecainide Acetate | 46 | $6,325 | $138 |
| Dofetilide | 25 | $5,754 | $230 |
| Amiodarone | 29 | $4,039 | $139 |
| Metoprolol | 101 | $2,253 | $22 |
| Sotalol | 14 | $564 | $40 |
| Carvedilol | 15 | $331 | $22 |
| Metoprolol | 14 | $119 | $8 |
| Cephalexin | 15 | $76 | $5 |
2021: 11 drugs
| Eliquis | 182 | $170,290 | $936 |
| Xarelto | 30 | $42,815 | $1,427 |
| Propafenone Hcl Er | 64 | $25,954 | $406 |
| Dofetilide | 32 | $12,144 | $380 |
| Flecainide Acetate | 50 | $4,443 | $89 |
| Metoprolol | 115 | $2,334 | $20 |
| Amiodarone | 18 | $2,107 | $117 |
| Propafenone | 14 | $1,631 | $117 |
| Sotalol | 19 | $581 | $31 |
| Metoprolol | 17 | $130 | $8 |
| Cephalexin | 11 | $59 | $5 |
2020: 12 drugs
| Eliquis | 165 | $140,963 | $854 |
| Xarelto | 32 | $43,447 | $1,358 |
| Propafenone Hcl Er | 45 | $25,900 | $576 |
| Dofetilide | 19 | $9,090 | $478 |
| Flecainide Acetate | 55 | $6,525 | $119 |
| Metoprolol | 135 | $3,796 | $28 |
| Propafenone | 24 | $2,487 | $104 |
| Diltiazem 24hr Er (Cd) | 19 | $2,074 | $109 |
| Amiodarone | 23 | $774 | $34 |
| Sotalol | 12 | $339 | $28 |
| Metoprolol | 13 | $104 | $8 |
| Cephalexin | 16 | $102 | $6 |
2019: 13 drugs
| Eliquis | 145 | $119,697 | $825 |
| Xarelto | 42 | $47,602 | $1,133 |
| Propafenone Hcl Er | 48 | $28,722 | $598 |
| Multaq | 13 | $8,994 | $692 |
| Dofetilide | 24 | $8,279 | $345 |
| Metoprolol | 102 | $3,994 | $39 |
| Flecainide Acetate | 40 | $3,859 | $96 |
| Diltiazem 24hr Er (Cd) | 22 | $2,997 | $136 |
| Amiodarone | 40 | $2,843 | $71 |
| Propafenone | 29 | $2,419 | $83 |
| Sotalol | 12 | $333 | $28 |
| Metoprolol | 16 | $138 | $9 |
| Cephalexin | 11 | $94 | $9 |
2018: 9 drugs
| Eliquis | 58 | $37,112 | $640 |
| Propafenone Hcl Er | 19 | $17,727 | $933 |
| Xarelto | 14 | $12,962 | $926 |
| Dofetilide | 16 | $6,741 | $421 |
| Metoprolol | 54 | $2,675 | $50 |
| Flecainide Acetate | 39 | $2,408 | $62 |
| Amiodarone | 27 | $957 | $35 |
| Cephalexin | 21 | $97 | $5 |
| Metoprolol | 18 | $77 | $4 |
2017: 10 drugs
| Propafenone Hcl Er | 35 | $23,767 | $679 |
| Eliquis | 35 | $19,214 | $549 |
| Xarelto | 22 | $18,486 | $840 |
| Metoprolol | 59 | $2,463 | $42 |
| Flecainide Acetate | 27 | $1,669 | $62 |
| Diltiazem 24hr Er | 12 | $541 | $45 |
| Sotalol | 12 | $487 | $41 |
| Amiodarone | 27 | $353 | $13 |
| Metoprolol | 16 | $87 | $5 |
| Cephalexin | 19 | $71 | $4 |
2016: 8 drugs
| Propafenone Hcl Er | 46 | $24,311 | $529 |
| Eliquis | 44 | $20,770 | $472 |
| Xarelto | 13 | $9,116 | $701 |
| Metoprolol | 73 | $2,848 | $39 |
| Flecainide Acetate | 30 | $1,484 | $49 |
| Amiodarone | 22 | $421 | $19 |
| Diltiazem 24hr Cd | 15 | $399 | $27 |
| Cephalexin | 14 | $70 | $5 |
2015: 11 drugs
| Propafenone Hcl Er | 43 | $31,034 | $722 |
| Eliquis | 25 | $9,788 | $392 |
| Xarelto | 13 | $7,051 | $542 |
| Metoprolol | 62 | $2,805 | $45 |
| Propafenone | 17 | $929 | $55 |
| Flecainide Acetate | 18 | $817 | $45 |
| Diltiazem 24hr Cd | 18 | $424 | $24 |
| Amiodarone | 23 | $416 | $18 |
| Losartan | 18 | $266 | $15 |
| Metoprolol | 28 | $145 | $5 |
| Cephalexin | 15 | $67 | $4 |
2014: 6 drugs
| Propafenone Hcl Er | 49 | $28,376 | $579 |
| Metoprolol | 79 | $3,764 | $48 |
| Flecainide Acetate | 13 | $696 | $54 |
| Amiodarone | 17 | $292 | $17 |
| Sotalol | 11 | $173 | $16 |
| Metoprolol | 24 | $173 | $7 |
2013: 10 drugs
| Propafenone | 64 | $26,100 | $408 |
| Xarelto | 17 | $7,820 | $460 |
| Pradaxa | 19 | $6,861 | $361 |
| Tikosyn | 21 | $5,330 | $254 |
| Metoprolol | 67 | $4,472 | $67 |
| Flecainide Acetate | 28 | $1,683 | $60 |
| Amiodarone | 21 | $482 | $23 |
| Midodrine | 16 | $422 | $26 |
| Sotalol | 16 | $319 | $20 |
| Metoprolol | 24 | $237 | $10 |
Money from drug and device companies
$44,028 in 2025
| 2025 | 9 | 46 | $38,590 | $44,028 |
| 2024 | 8 | 32 | $28,620 | $33,595 |
| 2023 | 8 | 50 | $25,895 | $31,769 |
| 2022 | 6 | 24 | $34,530 | $35,896 |
| 2021 | 4 | 15 | $19,500 | $20,354 |
| 2020 | 6 | 35 | $41,200 | $42,898 |
| 2019 | 9 | 54 | $50,300 | $58,482 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $32,466 | 16 payments
|
| Merit Medical Systems | Heartspan Steerable Sheath Introducer | $9,260 | 9 payments
|
| Abbott Laboratories | Aveir | $1,967 | 15 payments
|
| Biosense Webster | Carto 3 | $147 | 1 payment
|
| Amgen | Repatha | $50 | 1 payment
|
| Impulse Dynamics (USA) | Optimizer | $44 | 1 payment
|
See all 46 published payments
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Honoraria · 2025-12-17 | Lifevest | $5,000 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Travel · 2025-12-17 | Lifevest | $784 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Travel · 2025-12-04 | Lifevest | $470 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-12-03 | Lifevest | $124 |
| Abbott Laboratories | Meals · 2025-12-02 | Ensite Precision | $18 |
| Merit Medical Systems | Paid to speak or teach · 2025-11-26 | None | $4,550 |
| Merit Medical Systems | Travel · 2025-11-26 | None | $12 |
| Merit Medical Systems | Travel · 2025-11-26 | None | $5 |
| Merit Medical Systems | Travel · 2025-11-12 | None | $390 |
| Merit Medical Systems | Paid to speak or teach · 2025-11-12 | None | $4,040 |
| Merit Medical Systems | Travel · 2025-11-12 | None | $46 |
| Merit Medical Systems | Travel · 2025-11-12 | None | $36 |
| Merit Medical Systems | Travel · 2025-11-12 | None | $55 |
| Merit Medical Systems | Meals · 2025-10-29 | Heartspan Steerable Sheath Introducer | $126 |
| Amgen | Meals · 2025-10-21 | Repatha | $50 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Honoraria · 2025-10-15 | Lifevest | $5,000 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Paid to speak or teach · 2025-10-01 | Lifevest | $2,500 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Honoraria · 2025-09-17 | Lifevest | $5,000 |
| Abbott Laboratories | Meals · 2025-09-10 | Ensite Precision | $87 |
| Abbott Laboratories | Meals · 2025-08-26 | Ensite | $27 |
| Abbott Laboratories | Meals · 2025-08-26 | Aveir | $21 |
| Medtronic | Meals · 2025-08-21 | Micra | $41 |
| Boston Scientific | Meals · 2025-07-22 | Farapulse | $24 |
| Biosense Webster | Meals · 2025-06-27 | Carto 3 | $147 |
| Impulse Dynamics (USA) | Meals · 2025-05-22 | Optimizer | $44 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Honoraria · 2025-05-07 | Lifevest | $2,500 |
| Abbott Laboratories | Meals · 2025-04-14 | Ensite Precision | $14 |
| Abbott Laboratories | Meals · 2025-04-07 | Aveir | $110 |
| Abbott Laboratories | Meals · 2025-04-07 | Aveir | $85 |
| Abbott Laboratories | Meals · 2025-04-07 | Aveir | $50 |
| Abbott Laboratories | Meals · 2025-04-07 | Aveir | $209 |
| Abbott Laboratories | Meals · 2025-04-07 | Aveir | $190 |
| Abbott Laboratories | Meals · 2025-04-07 | Aveir | $49 |
| Abbott Laboratories | Travel · 2025-04-07 | Aveir | $723 |
| Abbott Laboratories | Travel · 2025-04-07 | Aveir | $153 |
| Abbott Laboratories | Travel · 2025-04-07 | Aveir | $222 |
| Abbott Laboratories | Travel · 2025-04-07 | Aveir | $9 |
| Cardiva Medical | Meals · 2025-04-04 | Cardiva Vascade Mvp Xl Vvcs 10-12f | $29 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Honoraria · 2025-02-12 | Lifevest | $5,000 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Travel · 2025-02-12 | Lifevest | $389 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Travel · 2025-01-29 | Lifevest | $249 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Travel · 2025-01-28 | Lifevest | $353 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-01-28 | Lifevest | $73 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-01-28 | Lifevest | $23 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Honoraria · 2025-01-22 | Lifevest | $2,500 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Honoraria · 2025-01-15 | Lifevest | $2,500 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $33,595
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $29,355 | 12 payments
|
| Cook | Evolution | $2,620 | 1 payment
|
| Abbott Laboratories | Aveir | $577 | 7 payments
|
| Boston Scientific | Emblem Mri S-Icd | $422 | 5 payments
|
| Medtronic | Micra | $230 | 2 payments
|
| Impulse Dynamics (USA) | Optimizer | $171 | 1 payment
|
| Biosense Webster | Carto 3 | $133 | 3 payments
|
| Cook Medical | Evolution | $87 | 1 payment
|
2023: $31,769
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $21,734 | 14 payments
|
| Cook | Evolution | $5,895 | 3 payments
|
| Abbott Laboratories | Aveir | $3,135 | 21 payments
|
| Impulse Dynamics (USA) | Optimizer | $463 | 6 payments
|
| Biosense Webster | Carto 3 | $221 | 3 payments
|
| Medtronic | Micra | $136 | 1 payment
|
| Cook Medical | Evolution | $100 | 1 payment
|
| Novartis Pharmaceuticals | Leqvio | $84 | 1 payment
|
2022: $35,896
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $20,914 | 9 payments
|
| Cook | Evolution | $14,030 | 5 payments
|
| AltaThera Pharmaceuticals | Sotalol Hydrochloride | $500 | 1 payment
|
| Impulse Dynamics (USA) | Optimizer | $260 | 1 payment
|
| Abbott Laboratories | Assurity | $160 | 7 payments
|
| Biotronik | Edora 8 Dr-T | $32 | 1 payment
|
2021: $20,354
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $19,577 | 8 payments
|
| Abbott Laboratories | Ensite Precision Cardiac Mapping System | $648 | 5 payments
|
| Biotronik | Biomonitor | $117 | 1 payment
|
| Cardiva Medical | Cardiva Vascade Mvp Vvcs 6-12f | $12 | 1 payment
|
2020: $42,898
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $26,247 | 15 payments
|
| Medtronic Vascular | Arctic Front | $6,308 | 10 payments
|
| Philips Electronics North America | (7999) Src Undivided | $6,000 | 1 payment
|
| Biotronik | None | $4,223 | 4 payments
|
| Cardiva Medical | Vascular Closure Device | $71 | 1 payment
|
| Abbott Laboratories | Perclose Proglide Suture Mediated Closure System | $49 | 3 payments
|
2019: $58,482
| Braemar Manufacturing | Cardiac Monitoring Suite | $33,000 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $20,508 | 19 payments
|
| Medtronic Vascular | Arctic Front | $3,517 | 12 payments
|
| Biotronik | Siello | $687 | 4 payments
|
| Respicardia | Remede System | $409 | 1 payment
|
| Abbott Laboratories | Confirm Rx | $117 | 1 payment
|
| Cook Medical | Cook Medical Lead Management - Lead Extraction | $110 | 2 payments
|
| Janssen Pharmaceuticals | Xarelto | $105 | 1 payment
|
| AngioDynamics | None | $31 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Cook Research Incorporated · Elease: Transvenous Lead Removal Using the Cook Evolution Lead Extraction · 2019 | Their institution | $354,424 |
| Medtronic Vascular, Inc. · Investigator Sponsored Research · 2019 | Their institution | $76,472 |
| Medtronic, Inc. · Investigator Sponsored Research · 2021 | Their institution | $58,675 |
| Medtronic Vascular, Inc. · Investigator Sponsored Research · 2020 | Their institution | $50,981 |
| Cook Research Incorporated · (16-04) Release: Transvenous Lead Removal Using the Cook Evolution Lead Extraction System · 2020 | Their institution | $23,205 |
| BOSTON SCIENTIFIC CORPORATION · Heartlogic Intervention Pilot · 2020 | Their institution | $14,713 |
| Boston Scientific Corporation · Manage Hf · 2019 | Their institution | $8,897 |
| Boston Scientific Corporation · Samurai · 2019 | Their institution | $4,408 |
| Boston Scientific Corporation · Manage Hf · 2021 | Their institution | $2,450 |
| Cook Research Incorporated · Cook Medical Lead Extraction · 2020 | This clinician | $1,653 |
| Cook Research Incorporated · Cook Medical Lead Extraction · 2019 | This clinician | $1,560 |
| Cook Research Incorporated · Ci-Lead: 16-04 Lead Management Clinical Study · 2020 | Their institution | $750 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 82.3 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1700835584
- Licence
- CA A54582California A54582: Current · expires 2027-01-31
- Trained
- Harvard Medical School, 1994
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00A545820
- Taxonomy
- Federal specialty code 207RC0001X (207RC0001X); Internal medicine (207R00000X); Cardiology (207RC0000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2006-05-09
- NPI last updated
- 2024-10-02
- NPI record certified
- 2024-10-02
This is when the NPI record was last certified, not a medical board exam.